Mouse Eggs Made with Stem Cells

Researchers claim to have successfully transformed stem cells into viable mouse oocytes that produced healthy, fertile pups.

Written byDan Cossins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Pups from oocytes made with iPSCs. Female offspring were fully fertile. Credit: Katsuhiko HayashiNew spermatozoa are seldom in short supply, but oocytes—immature egg cells—are much rarer, which has made the quest to generate oocytes from stem cells as challenging as it is important. Now, Japanese researchers claim to have succeeded in coaxing embryonic and adult stem cells from female mice into becoming fully functional oocytes capable of producing viable offspring via in vitro fertilization.

The study, published today (October 4) in Science, could pave the way for a more detailed characterisation of female germ line development. It could also help to save endangered species and may open new leads for treating human infertility.

“It’s a beautiful study, a tour de force,” said David Albertini, a physiologist at the University of Kansas Medical Centre, who was not involved in the study. “It’s the first clear demonstration that stem cells, either embryonic stem cells [ESCs] or induced plutipotent stem cells [iPSCs], can actually produce something that looks, smells, and tastes like an oocyte. They got bona fide oocytes that withstood the test of time by producing pups; that’s never been done before.”

“I think the importance is two-fold,” said Renee Reijo ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies